CNS Pharmaceuticals
Please add this description for CNS pharma: CNS Pharmaceuticals is a clinical-stage biopharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic central nervous system malignancies. The company is focused on advancing novel therapies with the goal of improving outcomes for patients with primary or secondary brain cancers.
Our lead program, TPI-287, crosses the blood–brain barrier and targets tumor cells within the brain. This approach represents a potential new treatment option for patients with glioblastoma, an aggressive and currently incurable form of brain cancer.
